A board to discuss future MS therapies in early stage (Phase I or II) trials.
Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.
- Family Elder
- Posts: 543
- Joined: Wed Jan 03, 2007 3:00 pm
- Location: Germany
Return to Drug Pipeline
Who is online
Users browsing this forum: No registered users